Life Healthcare Group Holdings Limited
LTGHY · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.01 | -1.31 | -2.04 |
| FCF Yield | 15.90% | 9.44% | 12.02% | 7.71% |
| EV / EBITDA | 16.02 | 5.64 | 12.20 | 10.71 |
| Quality | ||||
| ROIC | -5.83% | 11.58% | 4.98% | 5.19% |
| Gross Margin | 68.46% | 69.78% | 28.63% | 20.82% |
| Cash Conversion Ratio | -7.14 | 1.37 | 17.69 | 1.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 3.50% | -3.28% | -5.57% | 3.57% |
| Free Cash Flow Growth | 20.65% | -37.23% | 83.49% | -41.91% |
| Safety | ||||
| Net Debt / EBITDA | 0.14 | 0.44 | 3.66 | 3.30 |
| Interest Coverage | -1.47 | 6.87 | 4.22 | 7.74 |
| Efficiency | ||||
| Inventory Turnover | 19.40 | 16.55 | 36.38 | 15.37 |
| Cash Conversion Cycle | -18.86 | -14.27 | 26.11 | -20.14 |